clinical Information

    • DRAMP ID

    • DRAMP18083

    • Sequence

    • (CKPV)2

    • Sequence Name

    • CZEN-002

    • Description

    • synthetic 8-mer derived from α-melanocyte-stimulating hormone

    • Activity

    • anti-candidal

    • Medical use

    • Vulvovaginal candidiasis

    • Stage of Development

    • Phase IIb

    • Comments

    • Positive efficacy results announced. Phase IIb trial is a dose-ranging study

    • Company

    • Zengen(Woodland Hills, CA, USA)

    • Target Organism

      • No MICs found on DRAMP database

    • Reference

      • Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. (2006).